RLX Technology (RLX) is in focus after its Q2 2026 report, which combined 14.8% year over year revenue growth, an earnings miss versus expectations, and confirmation of a Western European acquisition and product expansion beyond e-vapor.

Despite the Q2 headlines, RLX Technology’s 1-day share price return declined 3%, with the 30-day share price return down 3.48% and the year to date share price return down 16.38%. The 3-year total shareholder return of 39.26% contrasts with a 5-year total shareholder return that declined 47.64%, which suggests earlier momentum has faded and more recent moves reflect investor reassessment of growth prospects and risks.

If you are weighing RLX against other growth stories around electrification and grid demand, it can help to scan 38 power grid technology and infrastructure stocks

RLX Technology now trades lower after the Q2 earnings miss, even as revenue and gross profit move in a different direction. Is that pullback an early entry point, or is patience still the better side of the trade given today’s valuation?

Most Popular Narrative: 34.8% Undervalued

RLX Technology's most followed valuation narrative sets a fair value of $2.98 per share, compared with the latest close at $1.94. That gap reflects a view that the current price does not fully reflect the company’s expansion plan and earnings profile under the model’s assumptions.

The ongoing global shift from traditional cigarettes to reduced-risk products, such as e-vapor and oral nicotine, is growing the overall nicotine alternatives market, RLX's leadership and early move into multi-category offerings position it to capture expanding consumer demand, supporting strong long-term revenue growth.

Read the complete narrative. Read the complete narrative.

Want to understand why this narrative supports a higher value for RLX Technology? The core of the model leans on faster revenue expansion, changing profit margins, and a richer future earnings multiple. Curious which of those inputs does most of the heavy lifting in the valuation?

Result: Fair Value of $2.98 (UNDERVALUED)

However, RLX Technology’s reliance on tightly regulated e-vapor markets, along with the scale of illegal competition in China, could still disrupt margins and mute the bullish narrative.

Another View On RLX Technology’s Valuation

The analyst narrative sees RLX Technology as 34.8% undervalued at $1.94 versus a $2.98 fair value. Our DCF model points the other way. It indicates the stock trades above an estimated future cash flow value of $1.04, which frames RLX as expensive based on that method. Which lens do you trust more when cash flows and multiples disagree?

To understand how this cash flow view is built and where the key pressure points sit, Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out RLX Technology for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 50 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Conflicted by the mixed signals around RLX Technology after this Q2 update? Take a closer look yourself and weigh both sides of the story. To see how current risks and potential rewards balance out, review the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond RLX Technology?

If RLX Technology is on your radar, do not stop there. Broaden your watchlist with other strong ideas that match your risk, income, and growth preferences.

• Spot potential mispricing early and review companies that screen as screener containing 18 high quality undiscovered gems before others catch on.
• Prioritise resilience and stability by scanning 83 resilient stocks with low risk scores that may better align with a cautious approach.
• Strengthen your core holdings with companies from the solid balance sheet and fundamentals stocks screener (50 results) that focus on financial robustness and quality fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.